Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Apr, 26 2025
Apr, 30 2026
Oct, 17 2025
Feb, 7 2026
Jan, 5 2026